IOCS 2025, Tokyo, Japan

We  hope you will save the date and plan to attend in Tokyo 2025. 

The  meeting will be held in collaboration with the Japanese Retina and Vitreous Society Meeting (JRVS) and the committee has been hard at work to make this a  very memorable event. As you may remember, our 2021 meeting in Kyoto had  to transition to virtual during the pandemic, and so we are excited to  be able to make this meeting. Special thanks to the leadership in JRVS  for supporting this very exciting collaboration!!  

 Abstract submission has 6 categories:

• Retinal Vascular Disease 
• Optical Coherence Tomography Angiography (OCTA) 
• Medical Retina and Perfusion
• Glaucoma
• Oculomics
• Other

Only members or members in training (supported by IOCS member) are allowed to submit as first authors.  IOCS Membership Application Here.

February 01                                     Abstract submission opens

March 31                                           Abstract submission closes

June 30                                             Abstract acceptance/rejection notification sent to First Authors

December 05                                  IOCS meeting in Tokyo Japan * This is a one-day meeting

*First  Authors of accepted abstracts will be required to register and pay for a  meeting registration fee and present their abstract.

**Any questions should be directed to   jasonmiaoportland@gmail.com and must include the abstract title and first/last name of the First Author.

IOCS Meeting President: Amani Fawzi (Northwestern University)

IOCS Meeting Program Chair: David Huang (Oregon Health & Science University)

International  Meeting Program Committee: Amani Fawzi (Northwestern University), Yali  Jia (Oregon Health & Science University), and Richard Rosen (New York  Eye and Ear Infirmary of Mount Sinai)

Japanese Meeting Program Co-Chair: Toshinori Murata (Shinshu University)

Japanese  Local Program Committee: Susumu Ishida (Hokkaido University), Fumi Gomi  (Hyogo College of Medicine), Yuichi Ogura (Nagoya City University  Hospital), Tomohiro Iida (Tokyo Women's Medical University Hospital),  and Toru Nakazawa  (Tohoku University)